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Effects of androgen on expression of OMgp of the HIBD
neonatal rat brain
Manling LIU1, Zhankui LI2

Aim: To investigate the protective effects of testosterone propionate (TP) on hypoxic–ischemic brain damage (HIBD)
neonatal rat brain by observing oligodendrocyte myelin glycoprotein (OMgp) expression in the cortex and hippocampus
after HIBD.
Materials and methods: Rats were randomly divided into 3 groups: TP pretreatment, HIBD control, and a sham
treatment group. Rats 7 days old from the TP group and HIBD control group were subjected to HIBD, and OMgp
expression in the hippocampus and cerebral cortex of the different doses and groups was observed after hypoxic–
ischemic induction at 24 h, 48 h, 72 h, 7 days, and 14 days.
Results: The OMgp expression in the brain tissue of the HIBD control group was significantly higher than that of the
sham group at the same point in time (P < 0.01). After intervention with TP, OMgp expression in the hippocampus and
cortex (30 mg/kg and 120 mg/kg) was significantly reduced compared with the HIBD control group (P < 0.01).
Conclusion: OMgp expression in neonatal rat brain tissues was increased after HIBD; OMgp overexpression was
inhibited after intervention with TP. Therefore, androgen may play an important role in removing inhibition of OMgp
on axon growth, and thus promote axonal regeneration, playing a protective role in the brain.
Key words: Oligodendrocyte cells, myelin glycoprotein, hypoxic–ischemic brain damage, testosterone propionate,
cortex, hippocampus

Introduction
Hypoxic–ischemic brain damage (HIBD) is a
common cause of damage to the neonatal central
nervous system, and is caused by perinatal hypoxia
and cerebral blood flow reduction or suspension
(1,2). There is a high mortality rate in children with
severe HIBD; most deaths happen in the neonatal
period, and survivors are left with varying degrees
of nervous system sequelae, such as cerebral palsy,
mental retardation, learning disabilities, and epilepsy.
Therefore, HIBD is a serious threat to children’s
health (3–5).

The oligodendrocyte myelin glycoprotein
(OMgp) is an important component of axonal growth
inhibition in central nervous system (CNS) myelin,
which is a specific glycoprotein within the CNS white
matter. It is now clear that OMgp inhibits axonal
growth, which can lead to growth cone collapse. The
human OMgp gene can inhibit cell proliferation, is
expressed by mature oligodendrocytes in both the
CNS and in the peripheral nervous system, and is
mainly located in the membrane (6–9). So far, almost
all research on OMgp expression in brain injury has
concentrated on adult rat ischemic brain injury, and
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has rarely focused on OMgp expression changes in
the brain tissues of neonatal rat brains after HIBD
damage.
Androgen is a hormone with the main function
to promote organ development of the reproductive
system and maintenance of secondary sexual
characteristics. Moreover, studies have reported that
androgen plays an important role in the brain’s normal
development, including differentiation, maintenance
of nerve function, and resistance to oxidative
damage. In recent years, it has been suggested that
androgen and its receptor play a protective role
against hypoxic–ischemic nerve injury (10,11).
In recent years, the in-depth study of nerve
regeneration has made axon regeneration
inhibitors a research hotspot. While OMgp is 1
of 3 myelin inhibitors of nerve growth, research
about the regulation of axon regeneration of HIBD,
particularly in OMgp expression change, is limited
at this time (12,13). Therefore, to further an indepth understanding of the neuroprotective roles
of androgen in the occurrence and development of
HIBD, we investigated the effects of androgen on
OMgp expression of excessive growth inhibitor of
axons in the HIBD rat brain tissue, using an HIBD
newborn rat model. This would provide a reliable
experimental and theoretical basis for finding new
therapeutic approaches to neonatal brain damage.
The purpose of this study was to explore the effects
of androgen pretreatment on OMgp expression
of HIBD hippocampus and cortex, and the dose
dependence of this relationship and its significance
for axonal regeneration.
Materials and methods
Animals
A total of 200 Sprague Dawley rats (3 days old, 6–10
g) were purchased from the Experimental Animal
Center of the Fourth Military Medical University,
Xi’an. They were housed at 21 ± 1 °C under a 12 h
light/12 h dark cycle and had free access to a standard
pellet diet (Purina chow) and tap water. Each
animal was used only once in the experiment. The
experimental protocols were approved by the Animal
Care and Use Committee of our institute.
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Drugs and reagents
The SABC immunohistochemistry kit and DAB
chromogenic kit were both purchased from the
Wuhan Boster Biological Engineering Co., Ltd. The
injection of testosterone propionate was purchased
from Shanghai GM Pharmaceutical Co., Ltd.
Experimental apparatus
The optical microscope was manufactured by
Japanese Olympus, the measuring oxygen analyzer
was produced by the Jiande Lida Instrument Factory,
and the computer image analysis equipment was
purchased from the German company Leica.
Animal groups and preparation of the animal model
Two hundred rats from the same growth conditions were
randomly divided into 3 groups: the sham group (n =
40), the HIBD control group (n = 80), and the androgen
group (n = 80). The androgen group and HIBD control
group were divided into 2 doses, so that in each dose
group there were 40 rats. At 3 days postpartum, each rat
from each dose of the androgen group was dosed with
testosterone propionate by intraperitoneal injection
(30 mg/kg and 120 mg/kg). Each rat from each dose
of the HIBD control group was separately given an
intraperitoneal injection with the corresponding
amount of peanut oil, once daily for 3 days.
Making the HIBD newborn rat model
The HIBD newborn rat model was established
according to the method described by Rice with some
modifications (14). The rats (7 days postpartum) were
placed in supine position, and their limbs were fixed
on the operating panel. After routine disinfection,
the neck incision was taken under anesthesia to
perform common carotid artery ligation on the
left, and finally the incision was sutured. The entire
surgical procedure took less than 10 min. Four hours
after the surgery, the rats were placed in a 10,000 mL
airtight container for 2.5 h, with an 8% O2/92% N2
gas mixture added at 2 L/min. For the sham group,
rats underwent the same surgical procedures, but
without the left common carotid artery ligation and
there was no hypoxia treatment.
Behavioral observations to determine the success of
the HIBD rat model
HIBD group: after hypoxia for about 10 min, all the
animals showed irritability; 30 min after hypoxia,
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animals showed cyanosis, shortness of breath, and
they demonstrated weakness with the hind legs
dragging while crawling; after hypoxia for 60 min,
most of the rats showed drowsiness or irritation to
phenomena, sometimes including twitching limbs
and incontinence; 1 h after reoxygenation, only a
small number of rats demonstrated much activity,
and most of those who showed activity rotated to the
left, suggesting that the model was successful.
Specimen preparation
Eight rats were taken from each group at 24 h, 48
h, 72 h, 7 days and 14 days after hypoxic–ischemic
induction (HI), respectively. After a 10% chloral
hydrate (40 mg/100 g) intraperitoneal injection of
anesthesia, the heart was exposed by thoracotomy,
and the right atrial appendage was cut. Intubation
through the left ventricle to the aorta allowed for a
rapid infusion of 20 mL of heparin saline, followed by
20 mL of 4% paraformaldehyde (4 °C), and then with
50 mL of 4% paraformaldehyde over a slow infusion
of 2 h. Then the whole brain was decapitated, and the
meninges removed. From this, 1/3 of the brain tissue
was coronally cut to 4 mm thick, and fixed in 4%
paraformaldehyde for 24 h, followed by a gradient of
alcohol and xylene dehydration. Finally the sample
was embedded in wax to prepare for sectioning into
serial 5 μm thick sagittal slices. Tissue sections were
stained with H&E by the routine procedure, and the
expression of OMgp in the brain tissues was assessed
by an immunohistochemical SABC assay.
Histopathological examination and determination
of OMgp
When the stained sections were observed with a light
microscope, the cytoplasm from OMgp-positive cells
showed brown particles. The LEICA QWIN image
signal acquisition and analysis system was used for
processing these results. Eight fields were randomly
selected in the cortex and hippocampus of each slice,
and then LEICA DC 300F software was applied to
measure the average optical density; the average
optical density reflects the immunohistochemical
staining intensity, suggesting that the deeper the color,
the stronger the expression. The average of 8 fields
was used to calculate the average optical density, the
average values of 2 slices from each sample were used
to calculate the sample test result, and the average

values of the 8 animals from each sample group were
used to calculate the group results.
Statistical analysis
All data were analyzed with GraphPad Prism 5
statistical software (GraphPad Software, Inc., San
Diego, CA, USA). Measurement data are presented
as mean ± standard deviation (SD), and comparisons
among groups used single factor analysis of variance
(ANOVA), with significance levels of P < 0.05 and P
< 0.01.
Results
The pathological changes in rat brain tissues
Under the microscope (Figure 1), rat brain tissues
in the sham group showed significant levels of brain
tissue structure, cell contours and a clear structure at
all time points (Figure 1A–B). In the HIBD control
group, 24 h after HI, the brain lesion was not obvious,
the left side of the brain showed necrosis after 48 h,
and after 72 h large areas of the left brain tissue also
showed necrosis. As a result, the number of neurons
decreased; nerve cells became disordered; cells
degenerated, showed necrosis, and collapsed; and the
cellular organizational structure was unclear. Cells
swelled, the cell nuclear membrane and nucleolus
were unclear, some cells were only a profile, as the
cell contents were released, and there was infiltration
of inflammatory cells. After 7 days, the proliferation
of glial cells and apoptosis of nerve cells appeared
around the lesions, apoptotic cells showed rounding
and cell shrinkage, and were out of contact with
neighboring cells, and the cell cytoplasm was darkly
stained. After 14 days, there was formation of the glial
scar around the cerebral cortex and hippocampus,
while the nerve cells showed degeneration,
necrosis, and inflammatory cell infiltration, and the
proliferation of glial cells and apoptotic nerve cells
appeared around the lesions (Figure 1C–D). The
necrosis and degeneration of nerve cells from the
androgen intervention group were less than that from
the HIBD group, the nerve cells from the androgen
intervention group were arranged in neat rows, and
the structure of the nerve cells from the androgen
intervention group were more complete than those
in the HIBD group. There was no clear infarction in
the androgen intervention group (Figure 1E–F).
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Figure 1. The pathological changes in rat brain tissues 7 days after HIBD.
HIBD = hypoxic–ischemic brain damage. Tissue sections of the tissues were H&E stained (magnification, ×400). (A) The
hippocampus of the sham group; (B) The cortex of the sham group; (C) The hippocampus of the control group (D) The cortex
of the control group (E) The hippocampus of the TP treated group (F) The cortex of the TP treated group.

The expression of OMgp in rat brain tissues from
different groups
OMgp expression was seen in the hippocampus and
cortex in the sham group (Figure 2A–B) and showed
changes in volatility over time, and the hippocampus
and cortex had synchronized fluctuations. After 24
1322

h, OMgp was expressed in the hippocampus and
cortex, after 48 h the average optical density of OMgp
increased, then decreased after 72 h, reached a peak
after 7 days, and after 14 days the average optical
density decreased. In the HIBD control group (Figure
2C–D), OMgp expression in the hippocampus and
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Figure 2. The expression of OMgp in rat brain tissues 7 days after HIBD.
HIBD = hypoxic–ischemic brain damage. Tissue sections were visualized by immunohistological staining (magnification,
×400). (A) OMgp expression in the hippocampus of the sham group; (B) OMgp expression in the cortex of the sham group;
(C) OMgp expression in the hippocampus of the control group (D) OMgp expression in the cortex of the control group.

cortex was higher than that of the sham group at each
time point, and there was a statistically significant
difference between the 2 groups (P < 0.01). Meanwhile,
in the hippocampus and cortex from the 2 dose
groups of the HIBD control group, OMgp expression
fluctuated over time distinctly from the sham group,
showing OMgp expression significantly increased 24
h after HI, which continued to rise at 48 h and 72
h, peaked at 7 days, and decreased at 14 days. These
values were always higher than the average optical
density values of the sham group at the same period.
The average difference of OMgp expression between
the 2 dose groups of the HIBD control groups, 30
mg and 120 mg, was not statistically significant (P >
0.05).
After androgen intervention, in both the
hippocampus and cortex the average optical density

of OMgp expression in both dose groups, 30 mg
and 120 mg, was significantly reduced at each time
point compared to the HIBD group (P < 0.01). OMgp
expression after treatment with either 30 mg or 120
mg of androgen was less than that of the sham group
(Figure 3) (P < 0.05). Both androgen treated groups
fluctuated in OMgp expression over time in the
hippocampus and cortex, similar to the HIBD control
group. At the same time, the difference in OMgp
expression between the 2 androgen dose groups was
not statistically significant (P > 0.05). The average
optical density of OMgp expression during each
period was slightly lower in the hippocampus than
in the cortex, but the difference was not statistically
significant (P > 0.05). OMgp expression from the left
hippocampus and cortex of rats is shown in Tables 1
and 2.
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Figure 3. The expression of OMgp in the brain of rat treated with TP 7 days after HIBD.
HIBD = hypoxic–ischemic brain damage, TP = testosterone propionate. Tissue sections were visualized by immunohistological
staining (magnification, ×400). (A) OMgp expression in the hippocampus after a dose of 30 mg/kg; (B) OMgp expression in
the cortex after a dose of 30 mg/kg; (C) OMgp expression in the hippocampus after a dose of 120 mg/kg (D) OMgp expression
in the cortex after a dose of 120 mg/kg.

Table 1. OMgp expression in the left hippocampus of rats after HI.

Group

The OMgp expression at different times after HI
24 h

48 h

72 h

7 days

14 days

Sham

0.177 ± 0.01

0.211 ± 0.01

0.202 ± 0.02

0.22 ± 0.02

0.186 ± 0.01

HIBD 30 mg

0.218 ± 0.02a

0.232 ± 0.03a

0.245 ± 0.02a

0.250 ± 0.01a

0.234 ± 0.01a

HIBD 120 mg

0.212 ± 0.02a

0.235 ± 0.02a

0.244 ± 0.01a

0.252 ± 0.01a

0.229 ± 0.02a

Androgen 30 mg

0.165 ± 0.02b

0.153 ± 0.02b

0.178 ± 0.01b

0.180 ± 0.02b

0.168 ± 0.01b

Androgen 120 mg

0.164 ± 0.02b

0.150 ± 0.03b

0.174 ± 0.01b

0.179 ± 0.01b

0.167 ± 0.01b

Values are presented as mean ± SD (n = 8). HI = hypoxic–ischemic; aP < 0.05, compared with the sham group; bP < 0.01,
compared with the same dose group from HIBD.
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Table 2. The OMgp expression in the left cerebral cortex of rats after HI.

Group

The OMgp expression at different time points after HI
24 h

48 h

72 h

7 days

14 days

Sham

0.188 ± 0.03

0.212 ± 0.01

0.203 ± 0.01

0.223 ± 0.02

0.189 ± 0.01

HIBD 30 mg

0.232 ± 0.02a

0.234 ± 0.02a

0.240 ± 0.02a

0.251 ± 0.02a

0.201 ± 0.02a

HIBD 120 mg

0.229 ± 0.02a

0.242 ± 0.05a

0.243 ± 0.03a

0.253 ± 0.01a

0.205 ± 0.03a

Androgen 30 mg

0.169 ± 0.04b

0.151 ± 0.01b

0.171 ± 0.02b

0.178 ± 0.02b

0.170 ± 0.02b

Androgen 120 mg

0.165 ± 0.02b

0.160 ± 0.02b

0.169 ± 0.01b

0.172 ± 0.02b

0.168 ± 0.01b

Values are presented as mean ± SD (n = 8). HI = hypoxic–ischemic; aP < 0.05, compared with the sham group; bP < 0.01,
compared with the same dose group from HIBD.

Discussion
Currently, the cellular and molecular mechanism of
HIBD is still unclear, and it remains difficult to find
an effective method for the prevention and treatment
of HIBD. The role of androgen and its receptor
in hypoxic–ischemic brain injury have received
increasing attention in recent years (15,16). Studies
have shown that androgen in hypoxic–ischemic
neurons can provide endogenous protection, and
that adding exogenous androgen can enhance this
protection (17–19). However, the neuroprotective
role of androgen in the neonatal HIBD model has
rarely been studied (20,21).
In the present study, using a neonatal rat HIBD
model, we observed the expression of OMgp in
newborn rat brain tissues at different time points
after HI, and observed the expression of OMgp in
newborn rat brain tissues after pretreating rats with
different doses of testosterone propionate. The results
showed that there was OMgp expression at all time
points in the rat hippocampus and cerebral cortex
in the sham group after surgery, the expression of
OMgp over time showed changes in volatility, and
fluctuations in OMgp levels in the hippocampus and
cortex were synchronized.
OMgp expression levels in the HIBD control
group were higher than that of the sham group at the
same time points, indicating that the expression levels

of the nueroinhibitor OMgp respond quickly after
HIBD. One week after the HI, expression of OMgp
reached its peak, but was maintained at a high level
afterwards. This suggests that the inhibiting protein
OMgp maintains a high level of expression for a long
time after HIBD, which may be a major cause for
CNS regeneration problems after injury. However,
our observations of OMgp expression in brain tissues
showed a slight difference from previous experiments.
Vourc’h used reverse transcriptase polymerase chain
reaction to analyze OMgp expression in some regions
of the postnatal rat CNS, and found that OMgp
expression had been increasing until 6 weeks after
birth. The proliferation of oligodendrocytes was also
at a peak before and after birth, with its mature and
immature myelin, and this synchronized with OMgp
expression. OMgp expression levels were consistent
with the myelination process, with expression peaking
in the final stage of myelin formation (22). The main
reasons for the inconsistency with our experiments
may be that the time frame of observation in this
experiment did not extend to 6 weeks postpartum.
In addition, the observational methods used were
different between the 2 studies, and these differences
may reflect changes to developmental maturity after
an injury to brain tissue. These results suggest that
OMgp expression is slightly different between brain
injuries that occur during development and brain
damage that occurs after maturity. In order to use
1325
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OMgp expression to promote axonal regeneration of
neurons in the central nervous system after injury,
it is important to understand the differences in
neuronal maturity and the type of brain damage.
To the best of our knowledge, there have been no
previous studies of testosterone propionate dosage in
neonatal rats. In preliminary experiments, the pretest dose had been the single dose (25 mg/kg); later
screening experiments dosed with 30 mg, 60 mg,
120 mg, 240 mg, or multiple increasing doses and it
was determined that 24 h after HIBD the best dose
was 30 mg/kg. In each dose group, there was only
a significant difference between the 30 mg/kg and
120 mg/kg groups. Previous experiments did not
show different time points after HI, and the timeand dose-dependence of the dynamic relationships
between the androgen dose and brain protection
was therefore not clear. Therefore, this experiment
was based on our preliminary studies, expanding
those studies by selecting 2 different doses (30 mg/
kg, 120 mg/kg), and time points of 24 h, 48 h, 72 h,
7 days, and 14 days after HI were selected. In each
dose group and at each time point there were 8 rats;
otherwise treatment between the groups was kept
constant to eliminate the extent of interfering factors
and to make the results more comparable.
The experimental results showed that when
pretreated with different doses of androgen, OMgp
expression in the hippocampus and cortex declined at
all the time points, which was statistically significant
when compared to the control group HIBD at the
same time point. These results also showed that, when
comparing the 30 mg/kg and 120 mg/kg dose groups,
OMgp expression decreased as the dose increased,
although this trend was not statistically significant.
OMgp expression was lower in the hippocampus
than in the cortex, but the trend was the same as
that of the cortex. Thus we had 2 conclusions: on
the one hand, testosterone propionate can reduce
the expression of OMgp of HIBD newborn rat
brains, so as to reduce levels of inhibitory factors,
and playing a role in brain protection; on the other
hand, the protective effect of testosterone propionate
at a dose of 30 mg/kg was best. The H&E staining
showed that necrosis and degeneration of nerve cells
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in the androgen intervention group was less than
that in the HIBD group at each time point. Brain
cells were arranged in neat rows, and the structure
of the nerve cells was incomplete compared to the
HIBD group, and there was no clear infarction. These
results indicated that the hormone could reduce the
expression of OMgp, preventing inhibition of axon
regeneration after HIBD, promote the recovery of
nerve cell morphology and axon regeneration, and
thus played a neuroprotective role.
Recent studies have confirmed that after cerebral
ischemia the glial cells are extremely active; there are
changes in hypertrophy and hyperplasia, which may
facilitate the growth and survival of neurons. Several
experimental studies have reported that regulating
glial cell morphology causes changes in its functions,
which to some extent inhibits the response of the glial
cells to injury (23,24). In this experiment, androgen
intervention decreases the expression of OMgp in rat
brain tissues at each time points after HI, and possibly
by regulating the cell morphology, structure and
function of the glial cells. Due to the regulatory role
of glial cells, decreased expression of OMgp in glial
cells at the site of brain injury results in decreased
expression of inhibitory axonal growth factors and
plays a neuroprotective role. This pathway may be
one of the mechanisms for promoting the functional
recovery of HIBD newborn rat brains. From the
point of view of androgen dose after HI, androgen at
30 mg/kg dose had a significant protective effect on
rat brain tissue. The average density measured solely
from the hippocampus and cortex using androgen of
120 mg/kg dose was lower than that of the 30 mg/
kg dose group, which appeared to inhibit the OMgp
expression in those brain tissues, but these differences
were not statistically significant.
In conclusions, After HIBD in neonatal rats, the
expression of OMgp increased, reaching its peak 7 days
after HI, and after 14 days the expression decreased to
higher than normal levels. After androgen intervention,
OMgp expression in brain tissues was reduced, which
resulted in a reduction in the inhibition of axon growth,
thereby promoting axonal regeneration and playing a
neuroprotective role. Androgen treatment at 30 mg/
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kg significantly suppresses the expression of OMgp
in the brain. Androgen intervention can promote
the recovery of nerve cell morphology after HIBD
and improve the brain’s structure, with a significant
neuroprotective effect.
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